Narrow Studies By:
—Disease/Health Benefits —
—Life Stage —
—Published Journal —
- Title [A-Z]
- Title [Z-A]
- Authors [A-Z]
- Authors [Z-A]
Plasma Phospholipid Long-Chain ω-3 Fatty Acids and Total and Cause-Specific Mortality in Older Adults: A Cohort StudyAuthors: D. Mozaffarian, et al. / Journal: Annals of Internal Medicine, April 2013
This is a 30-year study that looked at 2692 adults and compare mortality rates between those with higher plasma levels of omega-3 PUFA biomarkers with those who are lower. The study found those with higher omega-3 PUFA levels had a lower mortality rate than those who have less omega-3 PUFA levels. On average, those with higher levels lived 2.22 more years after age 65 years than those in the lowest quintile.
The survey is a 15-year follow up to the American Women's Awardness of Cardiovascular Disease Risk study. The survey compared women's view in 1997 and today and found that although women are more aware of heart disease as the leading cause of death, black and Hispanic women awareness remain low. The survey also found women 25-34 years hold had the lowest rate of awareness. The researchers urge for more lifestyle and prevent messages to spread awareness.
Inverse relationship between long-chain n-3 fatty acids and risk of sudden cardiac death in patients starting hemodialysisAuthors: A. N Friedman, et al. / Journal: Kidney International, February 2013
Experimental and clinical evidence suggests that long-chain n-3 fatty acids may protect against sudden cardiac death, the leading cause of mortality in hemodialysis patients. The study found significant inverse relationship was maintained even during the highest-risk first few months on hemodialysis. Thus, long-chain n-3 fatty acids are strongly and independently associated with a lower risk of sudden cardiac death in hemodialysis patients throughout the first year of hemodialysis.